Posted by AGORACOM-JC
at 9:43 AM on Tuesday, February 9th, 2021
Subject to customary governance approvals, Jamie P. Dwyer M.D. has joined as a member of the Board of Advisors of Draganfly.
Dr. Dwyer is a professor of medicine at Vanderbilt University, President of the Collaborative Study Group, and Co-Founder of Innovative Renal Care. Previously he served on the faculty of Mayo Clinic.
Los Angeles, CA, Feb. 09, 2021 — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, today announced, subject to customary governance approvals, Jamie P. Dwyer M.D. has joined as a member of the Board of Advisors of Draganfly.
Dr. Dwyer is a professor of medicine at Vanderbilt University, President of the Collaborative Study Group, and Co-Founder of Innovative Renal Care. Previously he served on the faculty of Mayo Clinic.
Dr. Dwyer has extensive experience working with FDA processes in particular devices and software.
Cameron Chell, CEO of Draganfly, said: “We are excited and truly honored to have Dr. Jamie Dwyer join Draganfly’s outstanding Board of Advisors. Dr. Dwyer brings an incredible understanding and experience with FDA processes and will be key in evolving our Vital Intelligence technology.”
“Draganfly has impressed me with the work they have done with their Smart Vital assessment platform and telehealth app. I am honored to assist a company that has built a solid foundation for innovation within the telehealth sector,” said Dr. Jamie Dwyer.
Dr. Dwyer holds an Sc.B degree in mathematics and Latin from Brown University, and an M.D. with Distinction from Brown University Medical School. He trained in Internal Medicine at Mayo Clinic Florida, where he served as Chief Medical Resident. He trained in Nephrology and Clinical Research at VUMC. After a faculty appointment at Mayo Clinic, he joined the Nephrology Division of VUMC in 2008.
Posted by AGORACOM-JC
at 10:47 AM on Thursday, February 4th, 2021
Investment to accelerate the production of innovative new technology while creating jobs
Ontario government is providing $2 million to CEM Specialties Inc. (“CEMSI“), a London based subsidiary of Kontrol Technologies Corp., through the Ontario Together Fund to help commercialize and accelerate production of Kontrol BioCloudTM, a COVID-19 detector.
Kontrol BioCloud (“BioCloudTM“), developed by CEMSI, is a made-in-Ontario real-time COVID-19 detection device that continuously monitors the presence of the SARS-COV-2 virus in the air.
TORONTO, ON / February 4, 2021 / Kontrol Technologies Corp.(CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol Technologies” or “Kontrol” or “Company“), is pleased to announce that the Ontario government is providing $2 million to CEM Specialties Inc. (“CEMSI“), a London based subsidiary of Kontrol Technologies Corp., through the Ontario Together Fund to help commercialize and accelerate production of Kontrol BioCloudTM, a COVID-19 detector.
“From day one, Ontario unleashed its innovation and manufacturing might in the fight against COVID-19, with businesses rolling out new innovations and products to help keep the frontlines and the general public safe,” said Vic Fedeli, Minister of Economic Development, Job Creation and Trade. “It’s the creativity and ingenuity of enterprising companies like CEMSI, with its innovative COVID-19 detection technology, that will help Ontario and the rest of the world successfully emerge from this pandemic, while creating hundreds of good jobs for our province’s skilled workers.”
Kontrol BioCloud (“BioCloudTM“), developed by CEMSI, is a made-in-Ontario real-time COVID-19 detection device that continuously monitors the presence of the SARS-COV-2 virus in the air. The technology promotes air circulation, monitors air quality and samples continuously for pathogens like viruses, bacteria and fungi. When the presence of the virus is detected, BioCloud provides an alert in the cloud or over a local intranet. The Company has received all approvals required to commercialize and produce the technology. Additional information about Kontrol BioCloud can be found on its website at www.kontrolbiocloud.com
With Ontario’s support, CEMSI plans to increase production capacity to 20,000 units per month. The product will be manufactured in London with more than 85 per cent of its components produced in province. The company anticipates accelerating the production of the BioCloud will create up to 250 direct jobs and up to 750 indirect jobs.
Posted by AGORACOM-JC
at 8:29 AM on Wednesday, February 3rd, 2021
Entered into a channel partnership agreement with SensorSuite Inc. to deliver SensorSuite’s Artificial Intelligence Energy Cloud Ecosystem Platform to multi-unit residential building and non-BAS customers across Canada
SensorSuite’s E.C.E platform seamlessly monitors, controls and optimizes Electricity, Gas and Water assets.
Using AI algorithms, the Energy Cloud Ecosystem aggregates and co-ordinates Distributed Energy Resources to eliminate wastage and increase operational efficiency.
Toronto, Ontario–(February 3, 2021) – Universal PropTech Inc. (TSXV: UPI) (“UPI” or the “Company“) is pleased to announce that it has entered into a channel partnership agreement (“Agreement“) with SensorSuite Inc. (“SensorSuite“) to deliver SensorSuite’s Artificial Intelligence (“AI“) Energy Cloud Ecosystem (“E.C.E“) Platform to multi-unit residential building (“MURB”) and non-BAS customers across Canada.
“Universal PropTech is pleased to bring SensorSuite’s AI platform to our MURB customers and prospects,” stated Chris Hazelton, President and CEO of UPI. “The inclusion of Artificial Intelligence is another tool in our expanding Building Performance offering to improve our evidence-based approach, ongoing services revenues and sustain our Trusted Advisor status.”
SensorSuite’s E.C.E platform seamlessly monitors, controls and optimizes Electricity, Gas and Water assets. Using AI algorithms, the Energy Cloud Ecosystem aggregates and co-ordinates Distributed Energy Resources to eliminate wastage and increase operational efficiency.
SensorSuite has deployed their AI solution in over 157 MURBs in Canada generating 12 billion data points per year. The Energy Cloud Ecosystem can generate between 20% to 30% in energy efficiency for MURB owners and managers, in an ongoing service model.
VCI Controls, a UPI wholly owned subsidiary, has provided services to over 2000 buildings in over 40 years, and will assess opportunities to generate Building Performance revenues with past, current customers and new prospects.
Glen Spry, President and CEO of SensorSuite, “We are excited to have Universal PropTech actively drive sales in Canada. Having a 40-year controls company like VCI Controls, enables us to start to scale the success of our AI Energy Cloud Ecosystem Platform.”
Posted by AGORACOM-JC
at 6:07 PM on Tuesday, February 2nd, 2021
On October 1st, the Ontario Securities Commission (OSC) and Investment Industry Regulatory Organization of Canada (IIROC) issued a press release in which they stated:
“As outlined in joint whistleblower guidance published today, the OSC and IIROC have reason to believe that certain market participants may be engaged in abusive short selling practices.”
and then announced this MASSIVE BOUNTY on predatory short sellers:
“Those who provide information to the OSC Whistleblower Program may be eligible for awards of up to $5 million for tips that lead to an OSC enforcement action.”
What effect has this had on the smallcap markets? Let’s look at the TSX Venture Index
On behalf of all small cap issuers, investors and service providers, we’re grateful to the OSC and IIROC for stepping up and putting their foot down.
However, none of this would have happened if it were not for the efforts of “Save Canadian Mining”, the lobbyist/advocacy group founded by Terry Lynch and backed by industry giants such as Eric Sprott, Sean Roosen, Keith Neumeyer and Rob McEwen and 3,000 + small cap investors who wrote the cheques necessary to hire the experts and analysts to help SCM make their case.
As such, if your Canadian small cap stock or stocks have appreciated nicely over the past 2 1/2 months without being hit by predatory short seller attacks, we should all be thanking SCM for their relentless and tireless work.
To this end, we were happy to interview Terry Lynch to find out if this 8 year nightmare is over and what final steps they are hoping to achieve with the Ontario Provincial Government, OSC, IIROC and CSA over the next 90 days to finally put an end to this. Watch this great interview.
Posted by AGORACOM-JC
at 8:44 AM on Monday, February 1st, 2021
Closed on the first $2.5 million of the $4 million Non-brokered Private Placement of Convertible Debenture Loan Notes each with a face value of $50,000 as originally announced in its Press Release dated January 25, 2021.
On January 27 and 28, 2021, there were closings of 40 and 10 Convertible Notes respectively, raising gross proceeds of $2.5 million.
MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX) is pleased to announce that it has closed on the first $2.5 million of the $4 million Non-brokered Private Placement of Convertible Debenture Loan Notes each with a face value of $50,000 (“Convertible Notes”) as originally announced in its Press Release dated January 25, 2021. On January 27 and 28, 2021, there were closings of 40 and 10 Convertible Notes respectively, raising gross proceeds of $2.5 million. The Convertible Notes will bear interest at 6% per year, payable Quarterly, and will mature on December 31, 2023 (the “Maturity Date”). The Convertible Notes may be converted, at the option of the Holder, into units at $0.14 per unit (“Unit”) at any time until the Maturity Date. Each Unit will be comprised of One (1) fully paid Common Share and One-half (1/2) of a Share Purchase Warrant. Each whole Share Purchase Warrant will be exercisable to purchase One (1) further Common Share at the price of $0.20, exercisable for a period expiring on the Maturity Date. The Company anticipates that it will close on further issuances of up to 30 more Convertible Notes, for up to a further $1.5 million. Closings will be subject to receipt of subscriptions and a number of other conditions, including without limitation the receipt of all relevant regulatory and Stock Exchange approvals or acceptances. The Convertible Notes, and any underlying securities, are subject to restriction from trading for a period of four months and one day from the respective dates of issuance. Qualified Agents may receive commissions in respect of subscriptions introduced by them by way of cash equal to 6% of funds so introduced, and issuance of agent’s warrants (“Agent’s Warrant(s)”) calculated by reference to 6% of the funds from subscribers introduced by such Agent. Each Agent’s Warrant, which is non-transferable, will be exercisable to acquire one Unit at $0.14 per Unit, at any time during the period up to the Maturity Date. In relation to the Closings already completed, a total of $129,000 has been paid by way of cash commissions and 407,143 Agent’s Warrants were issued. The Agent’s Warrants, and any underlying securities, are restricted from trading for a period of four months and one day from their respective dates of issuance.
Posted by AGORACOM-JC
at 8:28 AM on Monday, February 1st, 2021
Entered into an exclusive master distributor agreement with Air Alpine Innovation Research Inc. to promote and market Air Sniper products.
UPI’s wholly-owned subsidiary, VCI Controls Inc. will exclusively distribute these products in Ontario, Quebec and Atlantic Canada.
“We are excited to exclusively represent this Made-in-Canada success story of leading edge germicidal UVC and NASA-originated Photocatalytic Oxidation technology in Ontario, Quebec and Atlantic Canada,” stated Chris Hazelton,
Toronto, Ontario–(February 1, 2021) – Universal PropTech Inc. (TSXV: UPI) (“UPI” or the “Company“) is pleased to announce that it has entered into an exclusive master distributor agreement (“Agreement“) with Air Alpine Innovation Research Inc. (“Air Sniper“) to promote and market Air Sniper products. UPI’s wholly-owned subsidiary, VCI Controls Inc. (“VCI“) will exclusively distribute these products in Ontario, Quebec and Atlantic Canada.
“We are excited to exclusively represent this Made-in-Canada success story of leading edge germicidal UVC and NASA-originated Photocatalytic Oxidation technology in Ontario, Quebec and Atlantic Canada,” stated Chris Hazelton, President and CEO of UPI. “We will aggressively pursue immediate opportunities in schools, campuses, government and commercial facilities and seniors’ homes.”
Stuart Henley, President of Air Sniper said, “Air Sniper is pleased to enter into a partnership with Universal PropTech, and to be able to utilize their 40-year presence and experience in Ontario, Quebec and Atlantic Canada. With UPI’s existing and expanding client footprint, we expect to develop a strong partnership and see significant adoption as we work to push the Air Sniper product through sales funnels.”
Posted by AGORACOM-JC
at 8:23 AM on Monday, February 1st, 2021
Announced that it has completed its corporate name change
The Company’s CSE ticker symbol “KNR”, OTC Markets ticker symbol “KNRLF”, and Frankfurt Stock Exchange ticker symbol “1K8” will remain unchanged.
The Company’s common shares are expected to resume trading on the CSE under the name “Kontrol Technologies Corp.” on or about February 5, 2021.
TORONTO, ON / February 1, 2021 / Kontrol Technologies Corp. (formerly Kontrol Energy Corp.) (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol Technologies” or “Kontrol” or “Company“), is pleased to announce that it has completed its corporate name change (the “Name Change“) and continuation out of the Province of British Columbia under the provisions of the Business Corporations Act (British Columbia) into the Province of Ontario under the provisions of the Business Corporations Act (Ontario) (the “Continuance“), as approved by the shareholders of the Company at the Annual General and Special Meeting held on August 28, 2020. Copies of the certificate of continuation and the articles will be filed under the Company’s profile at www.sedar.com and www.thecse.com. There will be no change in the day-to-day business of the Company as a result of the Continuance.
The Company’s CSE ticker symbol “KNR”, OTC Markets ticker symbol “KNRLF”, and Frankfurt Stock Exchange ticker symbol “1K8” will remain unchanged. The Company’s common shares are expected to resume trading on the CSE under the name “Kontrol Technologies Corp.” on or about February 5, 2021. Trading under the name “Kontrol Technologies Corp.” is subject to approval from the Canadian Securities Exchange (CSE) and receipt of new CUSIP and ISIN numbers. The Company will update the market of the effective date of the name change once available.
“The name change to Kontrol Technologies Corp. better reflects our future and our brand,” says Paul Ghezzi, CEO of Kontrol. “We look forward to advancing our energy management, GHG emission and viral detection technologies, which form the foundation of our smart buildings and smart cities solutions.”
Kontrol Energy Group Inc. remains an operating subsidiary of Kontrol Technologies Corp.
Posted by AGORACOM-JC
at 8:16 AM on Monday, February 1st, 2021
Announce that Masa Ishimitsu has joined the Company as an Advisor to the CEO for the purposes of launching ImagineAR platform marketing and sales in Japan .
Mr. Ishimitsu is a former President of major companies in Japan including Solo Cup Japan & Asia Pacific Limited, SPXFlow Technology Japan, and Misawa Homes of America .
ImagineAR believes Mr. Ishimitsu will significantly accelerate the Company’s presence and sales throughout Japan and the Far East.
VANCOUVER, BC , Feb. 1, 2021 – ImagineAR (CSE: IP) (OTCQB: IPNFF) an Augmented Reality Company that enables sports teams, brands and businesses to instantly create their own mobile phone AR campaigns, is pleased to announce that Masa Ishimitsu has joined the Company as an Advisor to the CEO for the purposes of launching ImagineAR platform marketing and sales in Japan . Mr. Ishimitsu is a former President of major companies in Japan including Solo Cup Japan & Asia Pacific Limited, SPXFlow Technology Japan, and Misawa Homes of America . ImagineAR believes Mr. Ishimitsu will significantly accelerate the Company’s presence and sales throughout Japan and the Far East.
Masa Ishimitsu said “ImagineAR is the most advanced AR platform in the market today and I am excited to launch the company’s sales and marketing initiatives in Japan . Its simple platform means that organizations can almost instantly start engaging their customers and fans at a time when recovery and renewed market positions are essential. As consumers are slowly returning to stores and sports are coming back, information, offers and simple engagement will need to be more dynamic and shareable.”
Mr. Ishimitsu continued “ImagineAR lets marketing ideas get creative and conversations around brands to escalate, enabling experimentation at value and speed unlike other current AR solutions. AR industry in Japan is still at a very early stage of development and this means potentially a great opportunity for ImagineAR to capture market share. Also, Canada is my second home as I am a graduate of high school and the University in Victoria , B,C.. Having spent over 35 years in the international business, together with my bilingual and bicultural background, I am truly excited to be a part of Imagine AR’s team to develop the business in Japan .”
“Mr. Ishimitsu brings an impressive track record of success with major international companies expanding into Japan ,” said Alen Paul Silverrstieen, CEO and President of Imagine AR. “ImagineAR will continue our aggressive global expansion this year.”
This press release is available on the Company’s AGORACOM Discussion Forum , a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.
Posted by AGORACOM-JC
at 7:58 PM on Sunday, January 31st, 2021
Beyond Meat has become an $11 BILLION company by creating products designed to emulate beef. The basis of success has come from delivering the experience meat eaters have come to love (hamburgers, hot dogs, etc.) while also achieving the goal of eating healthier.
TAAT™ Beyond Tobacco™ mimics the experiences of cigarettes without nicotine or tobacco. It is engineered to closely emulate the sensory components of smoking a tobacco cigarette, including tasting and smelling just like tobacco.
E-cigarettes and vaping have failed despite existing for 15 years, driving most smokers back to cigarettes because they only perpetuate the problem of nicotine addiction while delivering a completely different user experience to smokers.
Under the leadership of experienced veterans from the tobacco industry, including and especially Philip Morris International, TAAT™ launched in the United States Just 7 weeks ago and has already received repeat orders from more than 60% of convenience and gas station customers.
How good was this launch?
“Out of all of the tobacco category products I have worked with, TAAT™ is an outlier in terms of the level of demand it has had in its early stages. I have launched dozens of new tobacco brands across Canada as well as in the Caribbean, and while many of the new products were reordered by retailers in their first several weeks on the market, none of them were reordered by anywhere near 60% of stores that initially carried them. …. I have confidence that we could replicate these outcomes both in Ohio and in other markets where we may introduce TAAT™ in the future.” – TAAT Chief Revenue Officer Tim Corkum (former commercialization executive for Philip Morris International)
How big is the market TAAT is going after? Tobacco is used by:
34M adults in America, equating to 215 BILLION cigarettes sold in 2018
1.3 billion people worldwide
… and almost all of them aspire to leave nicotine behind. Beyond Tobacco™ from TAAT is about to give them what they want and, if they succeed, give shareholders “Beyond Belief” returns in the next 2-3 years.
Watch this great interview with CEO Setti Coscarella!
Posted by AGORACOM-JC
at 8:15 AM on Friday, January 29th, 2021
Conference highlights industry leaders and innovators in the psychedelic therapy space and features Michael Pollan, author of New York Times bestseller, “How to Change Your Mind”
Will present at Canaccord Genuity’s “New Paradigms & Treatment Approaches in Mental Health” conference on February 3rd and 4th, 2021.
Two-day virtual conference will explore the science, intellectual property, and legality of psychedelic compounds, which are at the forefront of breakthrough medical science.
Novamind’s CEO and Director, Yaron Conforti will present on Wednesday February 3rd from 1:30-1:55 PM.
TORONTO, ON / January 29, 2021 / Novamind Inc. (CSE:NM) (“Novamind”), a mental health company specialized in psychedelic medicine, today announced that it will present at Canaccord Genuity’s “New Paradigms & Treatment Approaches in Mental Health” conference on February 3rd and 4th, 2021.
The two-day virtual conference will explore the science, intellectual property, and legality of psychedelic compounds, which are at the forefront of breakthrough medical science. Novamind’s CEO and Director, Yaron Conforti will present on Wednesday February 3rd from 1:30-1:55 PM.
Novamind, which has administered over 5,000 ketamine therapy treatments since 2016 and hosted over 20,000 client visits to its clinics in 2020 alone, will share its vision for scaling access to psychedelic medicine and advancing clinical research.
The conference will also feature keynote speaker Michael Pollan, author of the #1 New York Times bestseller “How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence.”
For more information about the conference, please click here.
